The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Early-life factors are associated with body mass index trajectories in children, with risk for obesity detectable at age 3.5 years.

Experienced weight stigma improves from pre- to post-metabolic bariatric surgery, according to a recent study.

Growth hormone was not associated with a lower risk for the composite liver outcome among patients with adult-onset craniopharyngioma.

More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

In a retrospective study, overlapping biologic therapy for ulcerative colitis or Crohn disease did not significantly increase risk of infections.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A plant-based diet rich in soy, regardless of processing, may benefit both hot flash and weight management in postmenopausal women.

Waist-to-height ratio had a better predictive value than BMI in assessing liver fibrosis and steatosis outcomes across ages and racial groups.

Less than half of United States adults are aware of the association between alcohol consumption and cancer risk.

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus FLOT yields better outcomes than FLOT alone.